yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Table
SPARQL
Graphs
2
2
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q27853086-64266B22-4631-4880-8EAF-9E05B32C652F
Q27853086-64266B22-4631-4880-8EAF-9E05B32C652F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27853086-64266B22-4631-4880-8EAF-9E05B32C652F
Cabozantinib overcomes crizotinib resistance in ROS1 fusion-positive cancer
P2860
Q27853086-64266B22-4631-4880-8EAF-9E05B32C652F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27853086-64266B22-4631-4880-8EAF-9E05B32C652F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0074cef0c7f342b6cb541fb37301e47f20bf7d49
P2860
ALK mutations conferring differential resistance to structurally diverse ALK inhibitors.